Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acamprosate in Pathological Gambling
NCT00571103Phase 4Completed
- Sponsor
- University of Iowa
- Start
- Oct 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of acamprosate in gambling disorder (GD), sponsored by University of Iowa. Primary endpoint: Yale-Brown Obsessive Compulsive Scale Modified for Pathological Gambling at 8 weeks. Started Oct 2007; status: completed.
02
Drugs
acamprosate
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on NCT00571103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00571103.